Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Cell therapy is emerging as a cutting-edge precision treatment in ophthalmology and is gaining immense popularity worldwide among people affected by degenerative eye diseases. Traditional therapies ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

In 2010, a milestone was achieved when the first patient with cancer was treated with CAR-T-cell therapy. This pioneering treatment modifies a patient's T cells by inserting a gene for a chimeric ...